Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Step by step instructions to Pick the Right Web-based Degree Program - 2Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
- 3Vacuum Cleaners That Are Not difficult To Use For Home
- 4Building a Maintainable Closet: Individual Excursions in Moral Style
- 5Select Your Cherished Fish
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Most loved Road Food: Which One Prevails upon You?
- Appreciate the World: Notable Caf\u00e9s You Want to Attempt
- 1st human missions to Mars should hunt for signs of life, report says
- The Significance of Health Projects in Senior Protection.
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- Picking the Right Pot for Your Plants: An Aide for Plant Devotees
- The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
